Barrier technology for TPN compounding; advantages and limitations.
Lee
M G
MG
D001207:Asepsis / Q000379:methods*; D004345:Drug Industry / Q000379:methods; D004780:Environment, Controlled; D006801:Humans; D010289:Parenteral Nutrition, Total / Q000592:standards*; D013678:Technology, Pharmaceutical / Q000592:standards*